The American Cancer Society estimates that approximately 29,590 women in the United States in 2018 will die from cancer of the reproductive system.
These cancers can be divided into
cervical, endometrial, and ovarian. To support research on these diseases, ATCC houses representatives of gynecological cancers from human and animal donors. We have also organized selected cell lines into Gynecological Cancer Cell Panels for high-throughput screening of chemotherapeutics. In addition, to support the researcher’s need for physiological controls for tumor cells ATCC provides human primary and hTERT-immortalized cells.
The cervix is sensitive to infection by human
papillomaviruses (HPV), which can lead to cellular
alterations resulting in cancer. For example, HeLa, the first
cell line to successfully be cultured continuously, is positive
for HPV. ATCC has 26 cervical cell lines to support your
research needs; explore the collection today!
Browse our cell lines
Endometrial cancers arise from the innermost
layer of the uterus. These cancers are the most commonly
diagnosed among reproductive cancers. While this cancer
is usually detected and treated early, it has been correlated
with taking hormone therapy for breast cancer. Browse our
collection of human and bovine uterine cells.
Search for cell lines
Because ovarian cancer is notoriously difficult to detect, it
stands highest in mortality among cancers of the female
reproductive system. To
help researchers investigate this killer, ATCC provides
ovarian cell lines, representing the normal and diseased
tissues of multiple species.
Explore the collection